Description
At a glance
| Attribute | Details |
|---|---|
| Active Compound | Long R3 IGF-1 |
| Chemical Classification | 83-AA Modified IGF-1 |
| Amount Per Vial | 1mg (1000 mcg) |
| Form | Lyophilized White Powder |
| Purity | ≥98% (HPLC Verified) |
| Half-Life | ~20-30 hours |
| Storage (Unreconstituted) | -20°C long-term, 2-8°C short-term |
| Storage (Reconstituted) | Refrigerated 2-8°C, use within 28-60 days |
| Shelf Life | 24 months unreconstituted when stored properly |
| Shipping | Plain packaging, ships from Canada |
| COA | Available on request for every batch |
This vial holds 1mg of lyophilized IGF-1 LR3, a modified form of IGF-1 with a 13-amino-acid N-terminal extension and an arginine substitution at position 3. These changes reduce binding to IGF-binding proteins, which is why it is studied for its extended half-life compared to native IGF-1. It is intended for laboratory and research use only, not for human or veterinary use.
Purity is verified at 98% or higher by HPLC, and a Certificate of Analysis is available on request for every batch. The peptide arrives as a freeze-dried powder that needs reconstitution with sterile bacteriostatic water before any research use. It ships from Canada in plain packaging.
Good to know
- Each vial contains 1mg of lyophilized IGF-1 LR3; adding 1mL of bacteriostatic water gives a concentration of 1000 mcg per mL.
- Store unreconstituted vials at -20°C for long-term storage or 2-8°C short-term; once reconstituted, keep refrigerated at 2-8°C and use within 28-60 days.
- Orders ship from Canada in plain outer packaging, and a Certificate of Analysis is available on request for this batch.
